Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 USD | -3.50% | -3.50% | -43.85% |
06/05 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
16/04 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- Press Releases